1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. North Carolina >
  6. Tivic Acquires Velocity Bioworks

M&A Deal Summary

Tivic Acquires Velocity Bioworks

On December 11, 2025, Tivic acquired life science company Velocity Bioworks from Scorpius Holdings

Acquisition Highlights
  • This is Tivic’s 1st transaction in the Life Science sector.
  • This is Tivic’s 2nd transaction in the United States.
  • This is Tivic’s 1st transaction in North Carolina.

M&A Deal Summary
Date 2025-12-11
Target Velocity Bioworks
Sector Life Science
Buyer(s) Tivic
Sellers(s) Scorpius Holdings
Deal Type Divestiture

Target

Velocity Bioworks

Durham, North Carolina, United States
Velocity Bioworks will offer integrated contract development and manufacturing services at its purpose-built, state-of-the-art facility in San Antonio. Velocity Bioworks focuses on rapidly advancing biologic programs to the clinic and will offer a broad array of analytical testing, process development, and manufacturing services. Velocity Bioworks is based in Durham, North Carolina.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Tivic

Fremont, California, United States
Category Company
Founded 2016
Sector Electronics
Employees7
Revenue 1M USD (2024)
DESCRIPTION

Tivic is a commercial-phase health technology company delivering non-invasive bioelectronic treatments that provide consumers with a choice in the treatment of inflammation and immune-related conditions. Tivic was formed in 2016 and is based in Fremont, California.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: North Carolina M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-10-17 Reliefband

Horsham, Pennsylvania, United States

Reliefband is neuromodulation (the alteration of nerve activity through targeted delivery of a stimulus to specific neurological sites in the body) and wearable technology company. The company devices are powered by proven science, objective data, and clinical research for the treatment of nausea and vomiting. Using highly effective and responsive technology, its digital wearable devices are clinically tested, FDA-cleared, and endorsed by the medical profession. Easy to use, comfortable and adjustable, they bring a life-changing approach to treatment so that people overcome life's uncomfortable moments. Reliefband was formed in 2015 and is based in Horsham, Pennsylvania.

Buy $34M

Seller(S) 1

SELLER

Scorpius Holdings

Morrisville, North Carolina, United States
Category Company
Founded 2008
Sector Life Science
Employees90
Revenue 6M USD (2024)
DESCRIPTION

Scorpius Holdings is a biopharmaceutical company involved in the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for cancers and infectious diseases. Scorpius Holdings was founded in 2008 and is based in Durham, North Carolina.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: North Carolina M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-21 Elusys Therapeutics

Parsippany, New Jersey, United States

Elusys Therapeutics is a commercial-stage biodefense company and the manufacturer of ANTHIM obiltoxaximab Injection. Elusys Therapeutics is based in Parsippany, New Jersey.

Buy -
Mergr

Solution for

Product

Company

Legal